SAN DIEGO, Aug 31, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
NewsMakers in the Biotech Industry Conference on September 6, 2007 at
10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) at the Millennium Broadway
Hotel in New York C...
SAN DIEGO, July 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) today reported financial results for the second quarter ended
June 30, 2007.
Total revenues in the second quarter of 2007 were $4.8 million, compared
to $9.3 million in the second quarter of 2006. Total revenues in the first
...
SAN DIEGO, July 18 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) today announced that it initiated dosing in a Phase 1 clinical
trial evaluating APD791, Arena's orally administered, internally discovered
drug candidate intended for the treatment of arterial thrombo-embolic
diseases. This Phase 1 trial is planned to...
SAN DIEGO, July 12 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) today announced it will report financial results for the second
quarter 2007 after the Nasdaq Global Market closes on Thursday, July 19, 2007.
That same afternoon, Jack Lief, Arena's President and Chief Executive Officer,
and Robert E. Hoffman, Arena'...
SAN DIEGO, June 8, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference on June 12,
2007 at 8:40 a.m. Pacific Time (11:40 a.m. Eastern Time) at the The
Ritz-Carlton Laguna N...
SAN DIEGO, June 7, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
Sixth Annual Needham & Company Biotechnology & Medical Technology Conference
on June 13, 2007 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) at the
New ...
SAN DIEGO, May 3 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
2007 UBS Global Generic and Specialty Pharmaceuticals Conference on
May 9, 2007 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) at the Grand
Hyatt Hotel in New York City. Dominic P. Be...
SAN DIEGO, May 18, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at
Citigroup's Global Healthcare Conference on May 24, 2007 at 11:00 a.m. Eastern
Time (8:00 a.m. Pacific Time) at the Hilton New York Hotel in New York City.
Dominic P. Be...
SAN DIEGO, May 3 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today the sale to an affiliate of BioMed Realty
Trust, Inc. of three properties owned and occupied by Arena and the assignment
to BioMed of an option to purchase a fourth property currently leased and
primarily occupied by Arena. Total consid...
SAN DIEGO, April 26 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
32nd Annual Deutsche Bank Health Care Conference on May 2, 2007 at 2:30 p.m.
Eastern Time (11:30 a.m. Pacific Time) at the Mayflower Hotel in Washington,
D.C. Dominic P. Behan, Ph.D., A...
SAN DIEGO, April 19 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
7th Annual Fortis Biotechnology Conference on Wednesday, April 25, 2007 at
10:00 a.m. British Summer Time (5:00 a.m. Eastern Time; 2:00 a.m. Pacific
Time) at the Four Seasons Hotel Park ...
SAN DIEGO, April 18 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) today reported financial results for the first quarter ended
March 31, 2007.
Total revenues in the first quarter of 2007 were $4.9 million, compared to
$12.1 million in the first quarter of 2006. Revenues in the first quarter of
2006 inc...
SAN DIEGO, April 11, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) today announced it will report first quarter 2007 financial
results after the NASDAQ Global Market closes on Wednesday, April 18, 2007.
That same afternoon, Jack Lief, Arena's President and Chief Executive Officer,
and Robert E...
SAN DIEGO, April 5, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
on Wednesday, April 11, 2007 at 9:45 a.m. Eastern Time (6:45 a.m. Pacific
Time) a...
SAN DIEGO, March 23 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at
BioCentury and Thomson Financial's 2007 Future Leaders in the Biotech Industry
Conference on Thursday, March 29, 2007 at 1:30 p.m. Eastern Time (10:30 a.m.
Pacific Time) at the Millennium Br...
SAN DIEGO, March 13, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
Lehman Brothers Tenth Annual Healthcare Conference on Monday, March 19, 2007
at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) at the Loews Miami Beach
Hotel. Rob...
SAN DIEGO, March 7 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
Cowen and Company 27th Annual Health Care Conference on Tuesday, March 13,
2007 at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time) at the Boston Marriott
Copley Place. William R. Shanaha...
SAN DIEGO, March 5 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) today announced that it initiated dosing in a Phase 2 clinical
trial of APD125 in chronic insomnia patients. APD125 is an orally available
drug candidate discovered by Arena with the potential to reduce insomnia
symptoms and improve sleep maintenance ...
SAN DIEGO, Feb. 23 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to participate at
the Susquehanna International Group's SIGnificant Investment Options in
Healthcare Conference on Thursday, March 1, 2007 at the Omni Berkshire Place
in New York City. David A. Walsey, Ar...
SAN DIEGO, Feb. 21 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) today announced it will report fourth quarter and full year
2006 financial results after the NASDAQ Global Market closes on Wednesday,
February 21, 2007. That same afternoon, Jack Lief, Arena's President and
Chief Executive Officer, and Robert E. Hof...
